VERTEX PHARMACEUTICALS INC / MA Commitments and Contingencies
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Commitments and Contingencies of $0 as of 2024-12-31, per its 10-K filed 2025-02-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:CommitmentsAndContingencies · last filed 2025-02-13
- 2024-12-31: Commitments and Contingencies $0.00.
- 2024-09-30: Commitments and Contingencies $0.00.
- 2024-06-30: Commitments and Contingencies $0.00.
- 2024-03-31: Commitments and Contingencies $0.00.
| Period end | Commitments and Contingencies |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-02 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-07 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-13 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-07 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-02 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-15 |
| 2022-09-30 | $0.00 10-Q · filed 2022-10-28 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-06 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-10 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-03 |
| 2021-06-30 | $0.00 10-Q · filed 2021-07-30 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-09 |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-30 |
| 2020-06-30 | $0.00 10-Q · filed 2020-07-31 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-01 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-11 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-13 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |